In recognition of National Influenza Vaccination Week (NIVW), our latest edition of the Guidelines+ Monographs Series will delve into the medication baloxavir marboxil, marketed under the brand name Xofluza® by Genentech. Xofluza is an influenza virus polymerase acidic (PA) endonuclease inhibitor indicated for the treatment of acute uncomplicated influenza in patients 5 years of age […]
Read More
Today, we will be looking into the latest research and clinical trials focused on thalassemia in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for thalassemia, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This compilation primarily […]
Read More
In this edition of our Guideline Spotlight, where we take a look into the significant changes and key takeaways from the Centers for Disease Control and Prevention’s (CDC) Recommended Childhood and Adolescent Immunization Schedule: United States, 2025. This schedule serves as a valuable tool for healthcare providers to determine the recommended vaccines for individuals within […]
Read More
November is recognized as National Prematurity Awareness Month, with World Prematurity Day being observed annually on November 17th to raise awareness about preterm birth. The incidence of preterm birth is increasing globally, with an estimated 15 million infants born preterm each year (more than 3 weeks early), as reported by the World Health Organization (WHO). […]
Read MoreWelcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication aflibercept, marketed under the brand name Eylea by Regeneron Pharmaceuticals, Inc. Eylea a is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD), Macular Edema […]
Read MoreThe United States Preventive Services Task Force (USPSTF) has recently released their draft recommendation statement on breastfeeding interventions. The statement, titled “Breastfeeding: Behavioral Counseling Interventions,” was published online on October 22, 2024. According to the latest screening guidelines, the USPSTF recommends providing or referring pregnant and postpartum individuals to interventions that support breastfeeding. These recommendations […]
Read More
The American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting was held in Seattle, Washington from October 14-19, 2024. This prestigious event serves as the largest gathering of child and adolescent psychiatrists globally, providing a valuable opportunity to engage with and learn from peers and colleagues from over 60 countries. The AACAP 2024 Annual […]
Read More
The 2024 American Academy of Pediatrics’ (AAP) National Conference & Exhibition was held from September 27 to October 1, 2024, in Orlando, FL. This event is a cornerstone for pediatric professionals, providing a plethora of educational opportunities such as updates on pediatric practice, cutting-edge research, and advocacy. Today, our focus is on the Vaccine & […]
Read More